Program Overview

Nano Cancer
Now Accepting Applications
for 2011

In anticipation of a nanotechnology-based transformation in the practice of tumor imaging and radiotherapy, Northwestern University has established a Cancer Education and Career Development program (R25), Cancer Nanotechnology in Imaging and Radiotherapy. This NCI-funded program will impart the necessary knowledge and skills to research-oriented radiologists and radiation oncologists who hope to participate in the process by which advances in nanotechnology research enter the clinic.

While the program is targeted to MDs who have just completed a residency in radiology or radiation oncology, it is also open to practicing clinicians in these specialties. The program will be directed by Gayle Woloschak, PhD, Professor of Radiation Oncology. It will operate under the auspices of the Robert H. Lurie Comprehensive Cancer Center, with strong support from the Depts. of Radiology and Radiation Oncology at Northwestern University and from the Depts. of Radiology and of Radiation and Cellular Oncology at the University of Chicago. The program will have strong links to Northwestern's Center for Cancer Nanotechnology Excellence.

This full-time, two to three year program will consist of formal coursework, supplementary educational experiences, participation in a laboratory-based cancer nanotechnology project, and participation in a cancer-related radiology or radiation oncology clinical study (see program requirements). Trainees will have the option of earning a Master of Science in Clinical Investigation. A stipend of $68,000 per year will be provided, along with an additional $20,000 stipend that can be used for tuition, attendance at scientific meetings, research expenses, etc. Trainees will have no clinical responsibilities.

To be eligible to apply, candidates must be U.S. citizens or permanent residents and must have completed an accredited Radiology or Radiation Oncology residency program or be in the last year of such a program. Interested candidates should submit a CV and letter of interest, including descriptions of any previous laboratory and clinical research experiences, to Dr. Gayle Woloschak ( on or before February 1. Based on these materials, selected candidates will be invited to submit full applications.